Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy? [electronic resource]
Producer: 20061025Description: 4668-9; author reply 4669 p. digitalISSN:- 1527-7755
- Antibiotics, Antineoplastic -- pharmacology
- Antineoplastic Agents -- adverse effects
- Capecitabine
- Clinical Trials as Topic -- methods
- Cohort Studies
- Data Interpretation, Statistical
- Deoxycytidine -- analogs & derivatives
- Erlotinib Hydrochloride
- Fluorouracil -- analogs & derivatives
- Gastrointestinal Tract -- drug effects
- Humans
- Middle Aged
- Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- Quinazolines -- pharmacology
- Research Design
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.